Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Allied Market Research | PRODUCT CODE: 1070543

Cover Image

PUBLISHER: Allied Market Research | PRODUCT CODE: 1070543

Hemodialysis Catheters Market by Product, Tip Configuration, Material, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030

PUBLISHED:
PAGES: 260 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 5769
PDF (5-user License)
USD 6929
PDF (Enterprise User License) & Excel (Data Pack) & Free Update
USD 10663

Add to Cart

The global hemodialysis catheters market was valued at $736 million in 2020 and expected to reach $1163 million in 2030, at a CAGR 4.66% from 2021 to 2030.

The process of blood filtration of an individual with kidney failure is called hemodialysis. Hemodialysis is a procedure that assists with filtering wastes and water from blood, for a patients suffering from kidney failure. Consequently, hemodialysis assists with controlling pulse and equilibrium of sodium, potassium, and calcium in the body, as a functional kidney would do . It is done by associating a dialysis machine to the patient involving a catheter as a connecting point. The catheter incorporates two sorts of lumens (adaptable tubular passage) for transmission of blood, which are hued in red and blue for clear identification during dialysis process. The red colored lumen (atrial lumen) draws blood from the patient and transmits it to the dialysis machine for filtration, while the blue hued lumen (venous lumen) returns the blood to the patient after filtration from dialysis machine.

The catheter is embedded in one of the huge veins, namely, superior vena cava or by penetrating the inner jugular vein in the neck to push it inside the chest.

The development of the hemodialysis catheters market is driven by variables, for example, increase in prevalence of end-stage renal diseases (ESRD) and increase in number of patients experiencing chronic kidney problems. Moreover, low accessibility of kidney donors for transplantation and innovative improvement in dialysis equipment fuel the market growth. However, surge in the price of dialysis procedures is considered as a major restraint for this market.

Moreover, rise in lifestyle disorders such as diabetes and hypertension are taking over the population and affecting the renal health of people.

The World Health Organization (WHO) on January 30, 2020 declared a global pandemic namely COVID-19. Coronavirus has impacted around 210 countries across the globe. As a precautionary measure the state run administration all over the globe declared a lockdown and social distancing practice. States have also given requirements and avoidances on undertakings and elective medical procedures. With surge in lockdown, there is rise in hypertension and diabetes, which, in turn, have affected the patients suffering from acute kidney injury (AKI) and chronic kidney disease (CKD). Therefore, they are relied on the dialysis industry for treatment but with expensive procedures they have also tend to restrain from the treatments. Thus COVID-19 had a neutral impact on the industry.

The hemodialysis catheters market is segmented on the basis of product, tip configuration, material, end user, and region. According to the product, the market is segregated into cuffed tunneled catheters, non-cuffed tunneled catheters and non-tunneled catheters. Depending on material, the market is categorized into silicone and polyurethane. As per tip configuration, it is classified into step-tip catheters, split-tip catheters, and symmetric catheters. By end user, it is fragmented into hospitals, clinics/dialysis centers, and home dialysis. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Major key players operating in hemodialysis catheters include Becton, Dickinson and Company, Omnicell Inc., Scriptpro Llc, Parata, Lonza, Baxter, Danaher, Capsa Healthcare, Cerner Corporation, RX Safe.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of four regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Product

  • Cuffed Tunneled Catheter
  • Non-cuffed Tunneled Catheters
  • Non-tunneled Catheters

By Tip Configuration

  • Step-tip Catheters
  • Split-tip Catheters
  • Symmetric Catheter

By Material

  • Silicone
  • Polyurethane

By End User

  • Hospitals
  • Home Dialysis
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Taiwan
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
Product Code: LI_172742 / A02409

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1.Report Description
  • 1.2.Key Market Segments
  • 1.3.Key Benefits
  • 1.4.Research Methodology
    • 1.4.1.Primary Research
    • 1.4.2.Secondary Research
    • 1.4.3.Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1.CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1.Market Definition and Scope
  • 3.2.Key Findings
    • 3.2.1.Top Investment Pockets
    • 3.2.2.Top Winning Strategies
  • 3.3.Porter's Five Forces Analysis
    • 3.3.1.Bargaining Power of Suppliers
    • 3.3.2.Threat of New Entrants
    • 3.3.3.Threat of Substitutes
    • 3.3.4.Competitive Rivalry
    • 3.3.5.Bargaining Power among Buyers
  • 3.4.Market Share Analysis/Top Player Positioning
    • 3.4.1.Market Share Analysis/Top Player Positioning 2020
  • 3.5.Market Dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6. COVID-19 Impact Analysis

CHAPTER 4: HEMODIALYSIS CATHETERS MARKET, BY PRODUCT

  • 4.1.Market Overview
  • 4.1.1Market Size and Forecast, By Product
  • 4.2.Cuffed Tunneled Catheter
    • 4.2.1.Key Market Trends, Growth Factors and Opportunities
    • 4.2.2.Market Size and Forecast, By Region
    • 4.2.3.Market Share Analysis, By Country
  • 4.3.Non Cuffed Tunneled Catheter
    • 4.3.1.Key Market Trends, Growth Factors and Opportunities
    • 4.3.2.Market Size and Forecast, By Region
    • 4.3.3.Market Share Analysis, By Country
  • 4.4.Non Tunneled Catheter
    • 4.4.1.Key Market Trends, Growth Factors and Opportunities
    • 4.4.2.Market Size and Forecast, By Region
    • 4.4.3.Market Share Analysis, By Country

CHAPTER 5: HEMODIALYSIS CATHETERS MARKET, BY TIP CONFIGURATION

  • 5.1.Market Overview
  • 5.1.1Market Size and Forecast, By Tip Configuration
  • 5.2.Step Tip Catheter
    • 5.2.1.Key Market Trends, Growth Factors and Opportunities
    • 5.2.2.Market Size and Forecast, By Region
    • 5.2.3.Market Share Analysis, By Country
  • 5.3.Split Tip Catheter
    • 5.3.1.Key Market Trends, Growth Factors and Opportunities
    • 5.3.2.Market Size and Forecast, By Region
    • 5.3.3.Market Share Analysis, By Country
  • 5.4.Symmetric Catheter
    • 5.4.1.Key Market Trends, Growth Factors and Opportunities
    • 5.4.2.Market Size and Forecast, By Region
    • 5.4.3.Market Share Analysis, By Country

CHAPTER 6: HEMODIALYSIS CATHETERS MARKET, BY MATERIAL

  • 6.1.Market Overview
  • 6.1.1Market Size and Forecast, By Material
  • 6.2.Silicone
    • 6.2.1.Key Market Trends, Growth Factors and Opportunities
    • 6.2.2.Market Size and Forecast, By Region
    • 6.2.3.Market Share Analysis, By Country
  • 6.3.Polyurethane
    • 6.3.1.Key Market Trends, Growth Factors and Opportunities
    • 6.3.2.Market Size and Forecast, By Region
    • 6.3.3.Market Share Analysis, By Country

CHAPTER 7: HEMODIALYSIS CATHETERS MARKET, BY END USER

  • 7.1.Market Overview
  • 7.1.1Market Size and Forecast, By End User
  • 7.2.Hospitals
    • 7.2.1.Key Market Trends, Growth Factors and Opportunities
    • 7.2.2.Market Size and Forecast, By Region
    • 7.2.3.Market Share Analysis, By Country
  • 7.3.Home Dialysis
    • 7.3.1.Key Market Trends, Growth Factors and Opportunities
    • 7.3.2.Market Size and Forecast, By Region
    • 7.3.3.Market Share Analysis, By Country
  • 7.4.Others
    • 7.4.1.Key Market Trends, Growth Factors and Opportunities
    • 7.4.2.Market Size and Forecast, By Region
    • 7.4.3.Market Share Analysis, By Country

CHAPTER 8: HEMODIALYSIS CATHETERS MARKET, BY REGION

  • 8.1.Market Overview
  • 8.1.1Market Size and Forecast, By Region
  • 8.2.North America
    • 8.2.1.Key Market Trends and Opportunities
    • 8.2.2.Market Size and Forecast, By Product
    • 8.2.3.Market Size and Forecast, By Tip Configuration
    • 8.2.4.Market Size and Forecast, By Material
    • 8.2.5.Market Size and Forecast, By End User
    • 8.2.6.Market Size and Forecast, By Country
    • 8.2.7.United States Hemodialysis Catheters Market
      • 8.2.7.1.Market Size and Forecast, By Product
      • 8.2.7.2.Market Size and Forecast, By Tip Configuration
      • 8.2.7.3.Market Size and Forecast, By Material
      • 8.2.7.4.Market Size and Forecast, By End User
    • 8.2.8.Canada Hemodialysis Catheters Market
      • 8.2.8.1.Market Size and Forecast, By Product
      • 8.2.8.2.Market Size and Forecast, By Tip Configuration
      • 8.2.8.3.Market Size and Forecast, By Material
      • 8.2.8.4.Market Size and Forecast, By End User
    • 8.2.9.Mexico Hemodialysis Catheters Market
      • 8.2.9.1.Market Size and Forecast, By Product
      • 8.2.9.2.Market Size and Forecast, By Tip Configuration
      • 8.2.9.3.Market Size and Forecast, By Material
      • 8.2.9.4.Market Size and Forecast, By End User
  • 8.3.Europe
    • 8.3.1.Key Market Trends and Opportunities
    • 8.3.2.Market Size and Forecast, By Product
    • 8.3.3.Market Size and Forecast, By Tip Configuration
    • 8.3.4.Market Size and Forecast, By Material
    • 8.3.5.Market Size and Forecast, By End User
    • 8.3.6.Market Size and Forecast, By Country
    • 8.3.7.France Hemodialysis Catheters Market
      • 8.3.7.1.Market Size and Forecast, By Product
      • 8.3.7.2.Market Size and Forecast, By Tip Configuration
      • 8.3.7.3.Market Size and Forecast, By Material
      • 8.3.7.4.Market Size and Forecast, By End User
    • 8.3.8.Germany Hemodialysis Catheters Market
      • 8.3.8.1.Market Size and Forecast, By Product
      • 8.3.8.2.Market Size and Forecast, By Tip Configuration
      • 8.3.8.3.Market Size and Forecast, By Material
      • 8.3.8.4.Market Size and Forecast, By End User
    • 8.3.9.U.K Hemodialysis Catheters Market
      • 8.3.9.1.Market Size and Forecast, By Product
      • 8.3.9.2.Market Size and Forecast, By Tip Configuration
      • 8.3.9.3.Market Size and Forecast, By Material
      • 8.3.9.4.Market Size and Forecast, By End User
    • 8.3.10.Italy Hemodialysis Catheters Market
      • 8.3.10.1.Market Size and Forecast, By Product
      • 8.3.10.2.Market Size and Forecast, By Tip Configuration
      • 8.3.10.3.Market Size and Forecast, By Material
      • 8.3.10.4.Market Size and Forecast, By End User
    • 8.3.11.Spain Hemodialysis Catheters Market
      • 8.3.11.1.Market Size and Forecast, By Product
      • 8.3.11.2.Market Size and Forecast, By Tip Configuration
      • 8.3.11.3.Market Size and Forecast, By Material
      • 8.3.11.4.Market Size and Forecast, By End User
    • 8.3.12.Rest Of Europe Hemodialysis Catheters Market
      • 8.3.12.1.Market Size and Forecast, By Product
      • 8.3.12.2.Market Size and Forecast, By Tip Configuration
      • 8.3.12.3.Market Size and Forecast, By Material
      • 8.3.12.4.Market Size and Forecast, By End User
  • 8.4.Asia-Pacific
    • 8.4.1.Key Market Trends and Opportunities
    • 8.4.2.Market Size and Forecast, By Product
    • 8.4.3.Market Size and Forecast, By Tip Configuration
    • 8.4.4.Market Size and Forecast, By Material
    • 8.4.5.Market Size and Forecast, By End User
    • 8.4.6.Market Size and Forecast, By Country
    • 8.4.7.Japan Hemodialysis Catheters Market
      • 8.4.7.1.Market Size and Forecast, By Product
      • 8.4.7.2.Market Size and Forecast, By Tip Configuration
      • 8.4.7.3.Market Size and Forecast, By Material
      • 8.4.7.4.Market Size and Forecast, By End User
    • 8.4.8.China Hemodialysis Catheters Market
      • 8.4.8.1.Market Size and Forecast, By Product
      • 8.4.8.2.Market Size and Forecast, By Tip Configuration
      • 8.4.8.3.Market Size and Forecast, By Material
      • 8.4.8.4.Market Size and Forecast, By End User
    • 8.4.9.Australia Hemodialysis Catheters Market
      • 8.4.9.1.Market Size and Forecast, By Product
      • 8.4.9.2.Market Size and Forecast, By Tip Configuration
      • 8.4.9.3.Market Size and Forecast, By Material
      • 8.4.9.4.Market Size and Forecast, By End User
    • 8.4.10.India Hemodialysis Catheters Market
      • 8.4.10.1.Market Size and Forecast, By Product
      • 8.4.10.2.Market Size and Forecast, By Tip Configuration
      • 8.4.10.3.Market Size and Forecast, By Material
      • 8.4.10.4.Market Size and Forecast, By End User
    • 8.4.11.South Korea Hemodialysis Catheters Market
      • 8.4.11.1.Market Size and Forecast, By Product
      • 8.4.11.2.Market Size and Forecast, By Tip Configuration
      • 8.4.11.3.Market Size and Forecast, By Material
      • 8.4.11.4.Market Size and Forecast, By End User
    • 8.4.12.Rest Of Asia-pacific Hemodialysis Catheters Market
      • 8.4.12.1.Market Size and Forecast, By Product
      • 8.4.12.2.Market Size and Forecast, By Tip Configuration
      • 8.4.12.3.Market Size and Forecast, By Material
      • 8.4.12.4.Market Size and Forecast, By End User
  • 8.5.LAMEA
    • 8.5.1.Key Market Trends and Opportunities
    • 8.5.2.Market Size and Forecast, By Product
    • 8.5.3.Market Size and Forecast, By Tip Configuration
    • 8.5.4.Market Size and Forecast, By Material
    • 8.5.5.Market Size and Forecast, By End User
    • 8.5.6.Market Size and Forecast, By Country
    • 8.5.7.Brazil Hemodialysis Catheters Market
      • 8.5.7.1.Market Size and Forecast, By Product
      • 8.5.7.2.Market Size and Forecast, By Tip Configuration
      • 8.5.7.3.Market Size and Forecast, By Material
      • 8.5.7.4.Market Size and Forecast, By End User
    • 8.5.8.Saudi Arabia Hemodialysis Catheters Market
      • 8.5.8.1.Market Size and Forecast, By Product
      • 8.5.8.2.Market Size and Forecast, By Tip Configuration
      • 8.5.8.3.Market Size and Forecast, By Material
      • 8.5.8.4.Market Size and Forecast, By End User
    • 8.5.9.South Africa Hemodialysis Catheters Market
      • 8.5.9.1.Market Size and Forecast, By Product
      • 8.5.9.2.Market Size and Forecast, By Tip Configuration
      • 8.5.9.3.Market Size and Forecast, By Material
      • 8.5.9.4.Market Size and Forecast, By End User
    • 8.5.10.Rest of LAMEA Hemodialysis Catheters Market
      • 8.5.10.1.Market Size and Forecast, By Product
      • 8.5.10.2.Market Size and Forecast, By Tip Configuration
      • 8.5.10.3.Market Size and Forecast, By Material
      • 8.5.10.4.Market Size and Forecast, By End User

CHAPTER 9: COMPANY PROFILES

  • 9.1.Becton, Dickinson And Company
    • 9.1.1.Company Overview
    • 9.1.2.Key Executives
    • 9.1.3.Company snapshot
    • 9.1.4.Operating business segments
    • 9.1.5.Product portfolio
    • 9.1.6.Business Performance
    • 9.1.7.Key Strategic Moves and Developments
  • 9.2.Baxter International Inc.
    • 9.2.1.Company Overview
    • 9.2.2.Key Executives
    • 9.2.3.Company snapshot
    • 9.2.4.Operating business segments
    • 9.2.5.Product portfolio
    • 9.2.6.Business Performance
    • 9.2.7.Key Strategic Moves and Developments
  • 9.3.AngioDynamics Inc.
    • 9.3.1.Company Overview
    • 9.3.2.Key Executives
    • 9.3.3.Company snapshot
    • 9.3.4.Operating business segments
    • 9.3.5.Product portfolio
    • 9.3.6.Business Performance
    • 9.3.7.Key Strategic Moves and Developments
  • 9.4.B.braun Melsungen Ag
    • 9.4.1.Company Overview
    • 9.4.2.Key Executives
    • 9.4.3.Company snapshot
    • 9.4.4.Operating business segments
    • 9.4.5.Product portfolio
    • 9.4.6.Business Performance
    • 9.4.7.Key Strategic Moves and Developments
  • 9.5.Cook Group
    • 9.5.1.Company Overview
    • 9.5.2.Key Executives
    • 9.5.3.Company snapshot
    • 9.5.4.Operating business segments
    • 9.5.5.Product portfolio
    • 9.5.6.Business Performance
    • 9.5.7.Key Strategic Moves and Developments
  • 9.6.Fresenius
    • 9.6.1.Company Overview
    • 9.6.2.Key Executives
    • 9.6.3.Company snapshot
    • 9.6.4.Operating business segments
    • 9.6.5.Product portfolio
    • 9.6.6.Business Performance
    • 9.6.7.Key Strategic Moves and Developments
  • 9.7.Medtronic, Inc.
    • 9.7.1.Company Overview
    • 9.7.2.Key Executives
    • 9.7.3.Company snapshot
    • 9.7.4.Operating business segments
    • 9.7.5.Product portfolio
    • 9.7.6.Business Performance
    • 9.7.7.Key Strategic Moves and Developments
  • 9.8.Nikkiso
    • 9.8.1.Company Overview
    • 9.8.2.Key Executives
    • 9.8.3.Company snapshot
    • 9.8.4.Operating business segments
    • 9.8.5.Product portfolio
    • 9.8.6.Business Performance
    • 9.8.7.Key Strategic Moves and Developments
  • 9.9.Nipro Corporation
    • 9.9.1.Company Overview
    • 9.9.2.Key Executives
    • 9.9.3.Company snapshot
    • 9.9.4.Operating business segments
    • 9.9.5.Product portfolio
    • 9.9.6.Business Performance
    • 9.9.7.Key Strategic Moves and Developments
  • 9.10.Toray Medical
    • 9.10.1.Company Overview
    • 9.10.2.Key Executives
    • 9.10.3.Company snapshot
    • 9.10.4.Operating business segments
    • 9.10.5.Product portfolio
    • 9.10.6.Business Performance
    • 9.10.7.Key Strategic Moves and Developments
Product Code: LI_172742 / A02409

LIST OF TABLES

  • TABLE 1.GLOBAL HEMODIALYSIS CATHETERS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 2.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR CUFFED TUNNELED CATHETER, BY REGION, 2020-2030 ($MILLION)
  • TABLE 3.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR NON CUFFED TUNNELED CATHETER, BY REGION, 2020-2030 ($MILLION)
  • TABLE 4.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR NON TUNNELED CATHETER, BY REGION, 2020-2030 ($MILLION)
  • TABLE 5.GLOBAL HEMODIALYSIS CATHETERS MARKET, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 6.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR STEP TIP CATHETER, BY REGION, 2020-2030 ($MILLION)
  • TABLE 7.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR SPLIT TIP CATHETER, BY REGION, 2020-2030 ($MILLION)
  • TABLE 8.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR SYMMETRIC CATHETER, BY REGION, 2020-2030 ($MILLION)
  • TABLE 9.GLOBAL HEMODIALYSIS CATHETERS MARKET, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 10.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR SILICONE, BY REGION, 2020-2030 ($MILLION)
  • TABLE 11.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR POLYURETHANE, BY REGION, 2020-2030 ($MILLION)
  • TABLE 12.GLOBAL HEMODIALYSIS CATHETERS MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 13.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 14.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR HOME DIALYSIS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 15.GLOBAL HEMODIALYSIS CATHETERS MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 16.GLOBAL HEMODIALYSIS CATHETERS MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 17.NORTH AMERICA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 18.NORTH AMERICA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 19.NORTH AMERICA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 20.NORTH AMERICA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 21.UNITED STATES HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 22.UNITED STATES HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 23.UNITED STATES HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 24.UNITED STATES HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 25.CANADA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 26.CANADA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 27.CANADA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 28.CANADA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 29.MEXICO HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 30.MEXICO HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 31.MEXICO HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 32.MEXICO HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 33.EUROPE HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 34.EUROPE HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 35.EUROPE HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 36.EUROPE HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 37.FRANCE HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 38.FRANCE HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 39.FRANCE HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 40.FRANCE HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 41.GERMANY HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 42.GERMANY HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 43.GERMANY HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 44.GERMANY HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 45.UNITED KINGDOM HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 46.UNITED KINGDOM HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 47.UNITED KINGDOM HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 48.UNITED KINGDOM HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 49.ITALY HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 50.ITALY HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 51.ITALY HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 52.ITALY HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 53.SPAIN HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 54.SPAIN HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 55.SPAIN HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 56.SPAIN HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 57.REST OF EUROPE HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 58.REST OF EUROPE HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 59.REST OF EUROPE HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 60.REST OF EUROPE HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 61.ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 62.ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 63.ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 64.ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 65.JAPAN HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 66.JAPAN HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 67.JAPAN HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 68.JAPAN HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 69.CHINA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 70.CHINA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 71.CHINA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 72.CHINA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 73.AUSTRALIA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 74.AUSTRALIA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 75.AUSTRALIA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 76.AUSTRALIA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 77.INDIA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 78.INDIA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 79.INDIA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 80.INDIA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 81.SOUTH KOREA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 82.SOUTH KOREA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 83.SOUTH KOREA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 84.SOUTH KOREA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 85.REST OF ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 86.REST OF ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 87.REST OF ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 88.REST OF ASIA-PACIFIC HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 89.LAMEA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 90.LAMEA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 91.LAMEA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 92.LAMEA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 93.BRAZIL HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 94.BRAZIL HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 95.BRAZIL HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 96.BRAZIL HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 97.SAUDI ARABIA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 98.SAUDI ARABIA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 99.SAUDI ARABIA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 100.SAUDI ARABIA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 101.SOUTH AFRICA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 102.SOUTH AFRICA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 103.SOUTH AFRICA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 104.SOUTH AFRICA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 105.REST OF LAMEA HEMODIALYSIS CATHETERS, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 106.REST OF LAMEA HEMODIALYSIS CATHETERS, BY TIP CONFIGURATION, 2020-2030 ($MILLION)
  • TABLE 107.REST OF LAMEA HEMODIALYSIS CATHETERS, BY MATERIAL, 2020-2030 ($MILLION)
  • TABLE 108.REST OF LAMEA HEMODIALYSIS CATHETERS, BY END USER, 2020-2030 ($MILLION)
  • TABLE 109.BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 110.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 111.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 112.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 113.BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114.BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
  • TABLE 115.BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 116.BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS
  • TABLE 117.BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
  • TABLE 118.BAXTER INTERNATIONAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119.ANGIODYNAMICS INC.: KEY EXECUTIVES
  • TABLE 120.ANGIODYNAMICS INC.: COMPANY SNAPSHOT
  • TABLE 121.ANGIODYNAMICS INC.: OPERATING SEGMENTS
  • TABLE 122.ANGIODYNAMICS INC.: PRODUCT PORTFOLIO
  • TABLE 123.ANGIODYNAMICS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124.B.BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 125.B.BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 126.B.BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 127.B.BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 128.B.BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129.COOK GROUP: KEY EXECUTIVES
  • TABLE 130.COOK GROUP: COMPANY SNAPSHOT
  • TABLE 131.COOK GROUP: OPERATING SEGMENTS
  • TABLE 132.COOK GROUP: PRODUCT PORTFOLIO
  • TABLE 133.COOK GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134.FRESENIUS: KEY EXECUTIVES
  • TABLE 135.FRESENIUS: COMPANY SNAPSHOT
  • TABLE 136.FRESENIUS: OPERATING SEGMENTS
  • TABLE 137.FRESENIUS: PRODUCT PORTFOLIO
  • TABLE 138.FRESENIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139.MEDTRONIC, INC.: KEY EXECUTIVES
  • TABLE 140.MEDTRONIC, INC.: COMPANY SNAPSHOT
  • TABLE 141.MEDTRONIC, INC.: OPERATING SEGMENTS
  • TABLE 142.MEDTRONIC, INC.: PRODUCT PORTFOLIO
  • TABLE 143.MEDTRONIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144.NIKKISO: KEY EXECUTIVES
  • TABLE 145.NIKKISO: COMPANY SNAPSHOT
  • TABLE 146.NIKKISO: OPERATING SEGMENTS
  • TABLE 147.NIKKISO: PRODUCT PORTFOLIO
  • TABLE 148.NIKKISO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149.NIPRO CORPORATION: KEY EXECUTIVES
  • TABLE 150.NIPRO CORPORATION: COMPANY SNAPSHOT
  • TABLE 151.NIPRO CORPORATION: OPERATING SEGMENTS
  • TABLE 152.NIPRO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 153.NIPRO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154.TORAY MEDICAL: KEY EXECUTIVES
  • TABLE 155.TORAY MEDICAL: COMPANY SNAPSHOT
  • TABLE 156.TORAY MEDICAL: OPERATING SEGMENTS
  • TABLE 157.TORAY MEDICAL: PRODUCT PORTFOLIO
  • TABLE 158.TORAY MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1.GLOBAL HEMODIALYSIS CATHETERS MARKET SEGMENTATION
  • FIGURE 2.GLOBAL HEMODIALYSIS CATHETERS MARKET
  • FIGURE 3.SEGMENTATION HEMODIALYSIS CATHETERS MARKET
  • FIGURE 4.TOP INVESTMENT POCKET IN HEMODIALYSIS CATHETERS MARKET
  • FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
  • FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
  • FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
  • FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 11.LOW THREAT OF SUBSTITUTION
  • FIGURE 12.HIGH COMPETITIVE RIVALRY
  • FIGURE 13.TOP PLAYER POSITIONING, 2020
  • FIGURE 14.MARKET SHARE ANALYSIS, 2020
  • FIGURE 15.RESTRAINTS AND DRIVERS: HEMODIALYSIS CATHETERS MARKET
  • FIGURE 16.HEMODIALYSIS CATHETERS MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 17.HEMODIALYSIS CATHETERS MARKET FOR CUFFED TUNNELED CATHETER, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 18.HEMODIALYSIS CATHETERS MARKET FOR NON CUFFED TUNNELED CATHETER, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 19.HEMODIALYSIS CATHETERS MARKET FOR NON TUNNELED CATHETER, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 20.HEMODIALYSIS CATHETERS MARKET SEGMENTATION, BY TIP CONFIGURATION
  • FIGURE 21.HEMODIALYSIS CATHETERS MARKET FOR STEP TIP CATHETER, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 22.HEMODIALYSIS CATHETERS MARKET FOR SPLIT TIP CATHETER, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 23.HEMODIALYSIS CATHETERS MARKET FOR SYMMETRIC CATHETER, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 24.HEMODIALYSIS CATHETERS MARKET SEGMENTATION, BY MATERIAL
  • FIGURE 25.HEMODIALYSIS CATHETERS MARKET FOR SILICONE, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 26.HEMODIALYSIS CATHETERS MARKET FOR POLYURETHANE, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 27.HEMODIALYSIS CATHETERS MARKET SEGMENTATION, BY END USER
  • FIGURE 28.HEMODIALYSIS CATHETERS MARKET FOR HOSPITALS, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 29.HEMODIALYSIS CATHETERS MARKET FOR HOME DIALYSIS, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 30.HEMODIALYSIS CATHETERS MARKET FOR OTHERS, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 31.BECTON, DICKINSON AND COMPANY: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 32.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 33.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 34.BAXTER INTERNATIONAL INC.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 35.BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 36.BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 37.ANGIODYNAMICS INC.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 38.ANGIODYNAMICS INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 39.ANGIODYNAMICS INC.: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 40.B.BRAUN MELSUNGEN AG: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 41.B.BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 42.B.BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 43.COOK GROUP: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 44.COOK GROUP: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 45.COOK GROUP: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 46.FRESENIUS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 47.FRESENIUS: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 48.FRESENIUS: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 49.MEDTRONIC, INC.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 50.MEDTRONIC, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 51.MEDTRONIC, INC.: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 52.NIKKISO: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 53.NIKKISO: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 54.NIKKISO: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 55.NIPRO CORPORATION: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 56.NIPRO CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 57.NIPRO CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 58.TORAY MEDICAL: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 59.TORAY MEDICAL: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 60.TORAY MEDICAL: REVENUE SHARE, BY REGION, 2020 (%)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!